NeoRx' OncoTrac
This article was originally published in The Gray Sheet
Executive Summary
Partner Boehringer Ingelheim files new product licensing application and B-I's subsidiary Dr. Karl Thomae GmbH files a new establishment licensing application for the NR-LU 10 monoclonal antibody diagnostic imaging agent kit for small cell lung cancer, NeoRx announces March 30. The Seattle-based company discovered in January 1992 that it had to conduct new clinicals and file a new PLA/ELA due to a change in the manufacturer for its MAb. Under a 1992 agreement, B-I has marketing rights for OncoTrac and Thomae will manufacture the product